Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss
NCT04701333Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabergoline in breast engorgement, sponsored by Stanford University. Started Apr 2021; status: completed.
02
Drugs
cabergoline
03
Conditions
breast engorgement
Beyond the preview
Go deeper on NCT04701333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04701333.